| Literature DB >> 17344888 |
S A Rempel1, R C Hawley, J A Gutiérrez, E Mouzon, K R Bobbitt, N Lemke, C R Schultz, L R Schultz, W Golembieski, J Koblinski, S VanOsdol, C G Miller.
Abstract
Sparc-null mice have been used as models to assess tumor-host immune cell interactions. However, it is not known if they have a competent immune system. In this study, the immune systems of Sparc wild-type and null mice were compared. Mice were assessed for differences in total body weight, spleen weight and spleen-to-body weight ratios. Spleens were compared with respect to morphology, and Sparc, Ki-67, MOMA-1 and IgM expression. Immune cells in blood, bone marrow and spleen were assessed by blood smears, automated blood panel, and flow cytometry. Additionally, the ability of Sparc-null mice to respond to immune challenge was evaluated using a footpad model. The morphological and immunohistochemical results indicated that Sparc-null spleens had more white pulp, hyperproliferative B cells in the germinal centers, and decreased marginal zones. Sparc-null spleens lacked normal Sparc expression in red and white pulp, marginal zones, endothelial and sinusoidal cells. By flow analysis, B cells were decreased and T cells were increased in the bone marrow. Finally, Sparc-null mice were unable to mount an immune response following footpad lipopolysaccharide challenge. These data confirm that Sparc-null mice have an impaired immune system.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17344888 DOI: 10.1038/sj.gene.6364388
Source DB: PubMed Journal: Genes Immun ISSN: 1466-4879 Impact factor: 2.676